TY - JOUR
T1 - Managing Intrathecal Drug Delivery (ITDD) in Cancer Patients
AU - Shah, Rajiv
AU - Baqai-Stern, Aisha
AU - Gulati, Amitabh
PY - 2015/6/30
Y1 - 2015/6/30
N2 - Pain is a commonly reported symptom in cancer patients. Patients with cancer pain often fail conservative medical management or have significant side effects to systemic medications. The implantation of an intrathecal drug delivery (ITDD) system may be the most effective treatment option for these patients and can improve their quality of life. This article aims to discuss the choice of intrathecal medications for patients suffering from intractable cancer pain, the management of ITDD throughout a patient’s disease course, and the management of complications related to the ITDD system and intrathecal medications.
AB - Pain is a commonly reported symptom in cancer patients. Patients with cancer pain often fail conservative medical management or have significant side effects to systemic medications. The implantation of an intrathecal drug delivery (ITDD) system may be the most effective treatment option for these patients and can improve their quality of life. This article aims to discuss the choice of intrathecal medications for patients suffering from intractable cancer pain, the management of ITDD throughout a patient’s disease course, and the management of complications related to the ITDD system and intrathecal medications.
KW - Cancer pain
KW - Intrathecal drug delivery
KW - Intrathecal medications
KW - Neuraxial trial
UR - http://www.scopus.com/inward/record.url?scp=84930658872&partnerID=8YFLogxK
U2 - 10.1007/s11916-015-0488-x
DO - 10.1007/s11916-015-0488-x
M3 - Review article
C2 - 26021753
AN - SCOPUS:84930658872
SN - 1531-3433
VL - 19
JO - Current Pain and Headache Reports
JF - Current Pain and Headache Reports
IS - 6
M1 - 20
ER -